Kiniksa Pharmaceuticals Ownership 2024 | Who Owns Kiniksa Pharmaceuticals Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

0.00%

Insider Ownership

4.15%

Retail Ownership

95.85%

Institutional Holders

2.00

Kiniksa Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BARCLAYS PLC0.05%0.00%34,839-7,308-17.34%650,000Jun 30, 2024
BIRCHVIEW CAPITAL, LP0.04%0.52%30,000--560,100Jun 30, 2024
ADIRONDACK TRUST CO0.00%0.01%875--16,266Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-623523523.00%11,631Jun 30, 2024
CWM, LLC0.00%-451311222.14%8,000Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----15,664-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----22,185-100.00%-Jun 30, 2024
US BANCORP \DE\----116-100.00%-Jun 30, 2024
M&T BANK CORP----36,334-100.00%-Jun 30, 2024
FRANKLIN RESOURCES INC----64,031-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----212,505-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----12,559-100.00%-Jun 30, 2024
NORTHERN TRUST CORP----290,644-100.00%-Jun 30, 2024
STATE STREET CORP----1,888,544-100.00%-Jun 30, 2024
VANGUARD GROUP INC----2,981,894-100.00%-Jun 30, 2024
ESSEX INVESTMENT MANAGEMENT CO LLC----172,740-100.00%-Jun 30, 2024
BARCLAYS PLC----30,000-100.00%-Jun 30, 2024
FMR LLC----2,331-100.00%-Jun 30, 2024
SEI INVESTMENTS CO----73,481-100.00%-Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP----506,299-100.00%-Jun 30, 2024

Kiniksa Pharmaceuticals's largest institutional shareholder is BARCLAYS PLC, holding 0.05% of the company's total share outstanding, currently valued at $650.00K. The top 10 institutional shareholders own together 0.09% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BIRCHVIEW CAPITAL, LP0.04%0.52%30,000--560,100Jun 30, 2024
ADIRONDACK TRUST CO0.00%0.01%875--16,266Jun 30, 2024
BARCLAYS PLC0.05%0.00%34,839-7,308-17.34%650,000Jun 30, 2024
CWM, LLC0.00%-451311222.14%8,000Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-623523523.00%11,631Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----15,664-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----22,185-100.00%-Jun 30, 2024
US BANCORP \DE\----116-100.00%-Jun 30, 2024
M&T BANK CORP----36,334-100.00%-Jun 30, 2024
FRANKLIN RESOURCES INC----64,031-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----212,505-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----12,559-100.00%-Jun 30, 2024
NORTHERN TRUST CORP----290,644-100.00%-Jun 30, 2024
STATE STREET CORP----1,888,544-100.00%-Jun 30, 2024
VANGUARD GROUP INC----2,981,894-100.00%-Jun 30, 2024
ESSEX INVESTMENT MANAGEMENT CO LLC----172,740-100.00%-Jun 30, 2024
BARCLAYS PLC----30,000-100.00%-Jun 30, 2024
FMR LLC----2,331-100.00%-Jun 30, 2024
SEI INVESTMENTS CO----73,481-100.00%-Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP----506,299-100.00%-Jun 30, 2024

The largest Kiniksa Pharmaceuticals shareholder by % of total assets is BIRCHVIEW CAPITAL, LP. The company owns 30.00K shares of Kiniksa Pharmaceuticals (KNSA), representing 0.52% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADVISOR GROUP HOLDINGS, INC.0.00%-623523523.00%11,631Jun 30, 2024
CWM, LLC0.00%-451311222.14%8,000Jun 30, 2024
ADIRONDACK TRUST CO0.00%0.01%875--16,266Jun 30, 2024
BIRCHVIEW CAPITAL, LP0.04%0.52%30,000--560,100Jun 30, 2024
PNC FINANCIAL SERVICES GROUP, INC.----8-100.00%-Jun 30, 2024
RIGGS ASSET MANAGMENT CO. INC.----30-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----34-100.00%-Jun 30, 2024
NISA INVESTMENT ADVISORS, LLC----58-100.00%-Jun 30, 2024
US BANCORP \DE\----116-100.00%-Jun 30, 2024
DAIWA SECURITIES GROUP INC.----139-100.00%-Jun 30, 2024
FORTITUDE FAMILY OFFICE, LLC----249-100.00%-Jun 30, 2024
TRUVESTMENTS CAPITAL LLC----447-100.00%-Jun 30, 2024
NATIONAL BANK OF CANADA /FI/----500-100.00%-Jun 30, 2024
PARALLEL ADVISORS, LLC----518-100.00%-Jun 30, 2024
CARMICHAEL HILL & ASSOCIATES, INC.----532-100.00%-Jun 30, 2024
LINDBROOK CAPITAL, LLC----660-100.00%-Jun 30, 2024
PACER ADVISORS, INC.----660-100.00%-Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----758-100.00%-Jun 30, 2024
GAMMA INVESTING LLC----854-100.00%-Jun 30, 2024
SIGNATUREFD, LLC----943-100.00%-Jun 30, 2024

As of Jun 30 2024, Kiniksa Pharmaceuticals's largest institutional buyer is ADVISOR GROUP HOLDINGS, INC.. The company purchased 523.00 stocks of KNSA, valued at $11.63K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.----4,193,907-100.00%-Jun 30, 2024
FAIRMOUNT FUNDS MANAGEMENT LLC----3,204,841-100.00%-Jun 30, 2024
HHLR ADVISORS, LTD.----3,135,735-100.00%-Jun 30, 2024
VANGUARD GROUP INC----2,981,894-100.00%-Jun 30, 2024
BAKER BROS. ADVISORS LP----2,809,577-100.00%-Jun 30, 2024
RUBRIC CAPITAL MANAGEMENT LP----2,196,009-100.00%-Jun 30, 2024
STATE STREET CORP----1,888,544-100.00%-Jun 30, 2024
PICTET ASSET MANAGEMENT HOLDING SA----1,460,633-100.00%-Jun 30, 2024
BRAIDWELL LP----1,392,716-100.00%-Jun 30, 2024
MORGAN STANLEY----1,270,613-100.00%-Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC----831,099-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----760,107-100.00%-Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC----725,511-100.00%-Jun 30, 2024
ARROWMARK COLORADO HOLDINGS LLC----666,976-100.00%-Jun 30, 2024
GRANAHAN INVESTMENT MANAGEMENT, LLC----648,087-100.00%-Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC----646,163-100.00%-Jun 30, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC----622,540-100.00%-Jun 30, 2024
RICE HALL JAMES & ASSOCIATES, LLC----618,798-100.00%-Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP----506,299-100.00%-Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC----500,000-100.00%-Jun 30, 2024

As of Jun 30 2024, Kiniksa Pharmaceuticals's biggest institutional seller is BLACKROCK INC.. The company sold -4.19M shares of KNSA, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.----4,193,907-100.00%-Jun 30, 2024
FAIRMOUNT FUNDS MANAGEMENT LLC----3,204,841-100.00%-Jun 30, 2024
HHLR ADVISORS, LTD.----3,135,735-100.00%-Jun 30, 2024
VANGUARD GROUP INC----2,981,894-100.00%-Jun 30, 2024
BAKER BROS. ADVISORS LP----2,809,577-100.00%-Jun 30, 2024
RUBRIC CAPITAL MANAGEMENT LP----2,196,009-100.00%-Jun 30, 2024
STATE STREET CORP----1,888,544-100.00%-Jun 30, 2024
PICTET ASSET MANAGEMENT HOLDING SA----1,460,633-100.00%-Jun 30, 2024
BRAIDWELL LP----1,392,716-100.00%-Jun 30, 2024
MORGAN STANLEY----1,270,613-100.00%-Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC----831,099-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----760,107-100.00%-Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC----725,511-100.00%-Jun 30, 2024
ARROWMARK COLORADO HOLDINGS LLC----666,976-100.00%-Jun 30, 2024
GRANAHAN INVESTMENT MANAGEMENT, LLC----648,087-100.00%-Jun 30, 2024
PARKMAN HEALTHCARE PARTNERS LLC----646,163-100.00%-Jun 30, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC----622,540-100.00%-Jun 30, 2024
RICE HALL JAMES & ASSOCIATES, LLC----618,798-100.00%-Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP----506,299-100.00%-Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC----500,000-100.00%-Jun 30, 2024
NORTHERN TRUST CORP----290,644-100.00%-Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.----261,698-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----239,409-100.00%-Jun 30, 2024
PEREGRINE CAPITAL MANAGEMENT LLC----236,045-100.00%-Jun 30, 2024
D. E. SHAW & CO., INC.----221,853-100.00%-Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC----216,908-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----212,505-100.00%-Jun 30, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP----185,813-100.00%-Jun 30, 2024
ESSEX INVESTMENT MANAGEMENT CO LLC----172,740-100.00%-Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC----164,568-100.00%-Jun 30, 2024
KNIGHTS OF COLUMBUS ASSET ADVISORS LLC----162,283-100.00%-Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC----159,323-100.00%-Jun 30, 2024
HUSSMAN STRATEGIC ADVISORS, INC.----157,500-100.00%-Jun 30, 2024
PRUDENTIAL FINANCIAL INC----156,210-100.00%-Jun 30, 2024
HUDSON BAY CAPITAL MANAGEMENT LP----151,000-100.00%-Jun 30, 2024
RAFFERTY ASSET MANAGEMENT, LLC----140,863-100.00%-Jun 30, 2024
LOS ANGELES CAPITAL MANAGEMENT LLC----139,850-100.00%-Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD----137,647-100.00%-Jun 30, 2024
LION POINT CAPITAL, LP----130,691-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----128,821-100.00%-Jun 30, 2024
NORDEA INVESTMENT MANAGEMENT AB----126,742-100.00%-Jun 30, 2024
HENNION & WALSH ASSET MANAGEMENT, INC.----124,878-100.00%-Jun 30, 2024
AMERIPRISE FINANCIAL INC----117,231-100.00%-Jun 30, 2024
LINDEN THOMAS ADVISORY SERVICES, LLC----116,381-100.00%-Jun 30, 2024
BANK OF NEW YORK MELLON CORP----112,580-100.00%-Jun 30, 2024
UBS GROUP AG----104,762-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----102,997-100.00%-Jun 30, 2024
UBS OCONNOR LLC----94,495-100.00%-Jun 30, 2024
DEUTSCHE BANK AG\----91,744-100.00%-Jun 30, 2024
HIGHVISTA STRATEGIES LLC----88,688-100.00%-Jun 30, 2024
WELLINGTON MANAGEMENT GROUP LLP----84,493-100.00%-Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----84,155-100.00%-Jun 30, 2024
MASSACHUSETTS FINANCIAL SERVICES CO /MA/----75,483-100.00%-Jun 30, 2024
TREXQUANT INVESTMENT LP----73,906-100.00%-Jun 30, 2024
SEI INVESTMENTS CO----73,481-100.00%-Jun 30, 2024
DARK FOREST CAPITAL MANAGEMENT LP----70,596-100.00%-Jun 30, 2024
LEGATO CAPITAL MANAGEMENT LLC----66,918-100.00%-Jun 30, 2024
FRANKLIN RESOURCES INC----64,031-100.00%-Jun 30, 2024
RHUMBLINE ADVISERS----61,431-100.00%-Jun 30, 2024
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC----61,106-100.00%-Jun 30, 2024
BREVAN HOWARD CAPITAL MANAGEMENT LP----59,954-100.00%-Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC----59,700-100.00%-Jun 30, 2024
PRINCIPAL FINANCIAL GROUP INC----58,991-100.00%-Jun 30, 2024
SWISS NATIONAL BANK----55,600-100.00%-Jun 30, 2024
JACKSON CREEK INVESTMENT ADVISORS LLC----54,384-100.00%-Jun 30, 2024
INVESCO LTD.----54,320-100.00%-Jun 30, 2024
JUMP FINANCIAL, LLC----50,078-100.00%-Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC----46,060-100.00%-Jun 30, 2024
MARTINGALE ASSET MANAGEMENT L P----45,377-100.00%-Jun 30, 2024
TEJARA CAPITAL LTD----42,649-100.00%-Jun 30, 2024
CAPULA MANAGEMENT LTD----41,242-100.00%-Jun 30, 2024
OPTIONS SOLUTIONS, LLC----40,205-100.00%-Jun 30, 2024
NEW YORK STATE COMMON RETIREMENT FUND----39,771-100.00%-Jun 30, 2024
ALLIANCEBERNSTEIN L.P.----39,560-100.00%-Jun 30, 2024
M&T BANK CORP----36,334-100.00%-Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC----34,062-100.00%-Jun 30, 2024
BARCLAYS PLC----30,000-100.00%-Jun 30, 2024
CERITY PARTNERS LLC----29,683-100.00%-Jun 30, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM----28,662-100.00%-Jun 30, 2024
ALPS ADVISORS INC----28,203-100.00%-Jun 30, 2024
STRS OHIO----28,100-100.00%-Jun 30, 2024
JANNEY MONTGOMERY SCOTT LLC----26,843-100.00%-Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.----26,200-100.00%-Jun 30, 2024
LEGAL & GENERAL GROUP PLC----25,995-100.00%-Jun 30, 2024
CAMPBELL & CO INVESTMENT ADVISER LLC----22,557-100.00%-Jun 30, 2024
VIRTUS ETF ADVISERS LLC----22,347-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----22,185-100.00%-Jun 30, 2024
PROFUND ADVISORS LLC----22,026-100.00%-Jun 30, 2024
AMERICAN CENTURY COMPANIES INC----21,912-100.00%-Jun 30, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.----20,935-100.00%-Jun 30, 2024
SG AMERICAS SECURITIES, LLC----19,160-100.00%-Jun 30, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----17,856-100.00%-Jun 30, 2024
MERCER GLOBAL ADVISORS INC /ADV----17,689-100.00%-Jun 30, 2024
METLIFE INVESTMENT MANAGEMENT, LLC----17,349-100.00%-Jun 30, 2024
VICTORY CAPITAL MANAGEMENT INC----17,141-100.00%-Jun 30, 2024
VESTCOR INC----17,000-100.00%-Jun 30, 2024
HSBC HOLDINGS PLC----16,356-100.00%-Jun 30, 2024
ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V.----15,982-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----15,664-100.00%-Jun 30, 2024
QRG CAPITAL MANAGEMENT, INC.----15,178-100.00%-Jun 30, 2024

Kiniksa Pharmaceuticals's largest sold out institutional shareholder by shares sold is BLACKROCK INC., sold -4.19M shares, valued at -, as of undefined.

Kiniksa Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
WANGER ADVISORS TRUST0.50%272,453--Mar 31, 2024
COLUMBIA ACORN TRUST0.34%1,098,682--Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.04%21,265--Mar 31, 2024
FORUM FUNDS II0.01%14,0348586.51%Mar 31, 2024
Humankind Benefit Corp0.01%248--Dec 31, 2023
DRIEHAUS MUTUAL FUNDS0.01%79,516-495-0.62%Mar 28, 2024
VANGUARD INDEX FUNDS0.01%2,632,759-453,501-14.69%Mar 31, 2024
CLEARWATER INVESTMENT TRUST0.00%47,116--Mar 28, 2024
ALPS ETF Trust0.00%43,040-25,965-37.63%Feb 29, 2024
Destra Investment Trust0.00%5,5073917.64%Mar 31, 2024
JAMES ADVANTAGE FUNDS0.00%6,909--Dec 31, 2023
TIAA SEPARATE ACCOUNT VA 10.00%706--Mar 31, 2024
VANGUARD EXPLORER FUND0.00%36,699--Jan 31, 2024
TIAA-CREF LIFE FUNDS0.00%7,642-251-3.18%Mar 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%186,740--Jan 31, 2024
Nushares ETF Trust0.00%14,683--Jan 31, 2024
TIMOTHY PLAN0.00%7,9911,07115.48%Mar 31, 2024
VICTORY PORTFOLIOS0.00%43,640--Mar 31, 2024
VANGUARD HORIZON FUNDS0.00%22,257--Mar 31, 2024
OHIO NATIONAL FUND INC0.00%17,844--Mar 31, 2024
Brinker Capital Destinations Trust0.00%40,976-16,853-29.14%Feb 29, 2024
ProFunds0.00%7,3971,76031.22%Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%18,485-1,456-7.30%Mar 31, 2024
Direxion Shares ETF Trust0.00%92,039-17,202-15.75%Jan 31, 2024
PUTNAM ASSET ALLOCATION FUNDS0.00%18,747-294-1.54%Mar 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%27,696--Mar 31, 2024
RBB FUND, INC.0.00%44,56610,87932.29%Feb 29, 2024
Columbia Funds Variable Series Trust II0.00%14,105--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%96,9814,5444.92%Jan 31, 2024
VANGUARD WORLD FUND0.00%96,4312,1062.23%Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%407,486396,1653499.38%Mar 31, 2024
Global X Funds0.00%15,634--Jan 31, 2024
North Square Investments Trust0.00%3,366--Jan 31, 2024
Dimensional ETF Trust0.00%110,91381,213273.44%Jan 31, 2024
Trust for Advised Portfolios0.00%4,367--Dec 31, 2023
GPS Funds I0.00%1,118--Mar 31, 2024
AMERICAN CENTURY ETF TRUST0.00%21,7292,21311.34%Feb 29, 2024
Invesco Exchange-Traded Self-Indexed Fund Trust0.00%41,73130,954287.22%Feb 29, 2024
NORTHERN FUNDS0.00%26,583-3,740-12.33%Mar 28, 2024
NEW COVENANT FUNDS0.00%801--Dec 31, 2023
ALLSPRING MASTER TRUST0.00%9,508--Feb 29, 2024
TIAA-CREF FUNDS0.00%389,911--Jan 31, 2024
Meeder Funds0.00%496--Mar 31, 2024
Victory Portfolios II0.00%3,97393730.86%Mar 31, 2024
Columbia Funds Series Trust II0.00%25,964--Jan 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%137,40013,95011.30%Feb 29, 2024
THRIVENT MUTUAL FUNDS0.00%6,122--Mar 28, 2024
VANGUARD WELLINGTON FUND0.00%21,7009,35375.75%Feb 29, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%141,651-90,335-38.94%Dec 31, 2023
THRIVENT SERIES FUND INC0.00%3,209--Mar 28, 2024
PGIM ETF TRUST0.00%1,914--Feb 29, 2024
WILSHIRE MUTUAL FUNDS INC0.00%8,53550.06%Dec 31, 2023
MUTUAL FUND SERIES TRUST0.00%110,000--Mar 31, 2024
EMPOWER FUNDS, INC.0.00%23,95723,957-Mar 31, 2024
ALLSPRING FUNDS TRUST0.00%8,438--Jan 31, 2024
HC CAPITAL TRUST0.00%442--Mar 31, 2024
Pacer Funds Trust0.00%524-373-41.58%Jan 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,073--Feb 29, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%514--Dec 31, 2023
ETF Series Solutions0.00%183--Jan 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%126,55442,35950.31%Feb 29, 2024
COLUMBIA FUNDS SERIES TRUST I0.00%27,381--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%11,869-500-4.04%Mar 31, 2024
Invesco Exchange-Traded Fund Trust II0.00%94333053.83%Feb 29, 2024
Bridge Builder Trust0.00%13,147-338-2.51%Mar 31, 2024
Investment Managers Series Trust0.00%3,175--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%2,269--Dec 31, 2023
Advisors' Inner Circle Fund III0.00%1021821.43%Jan 31, 2024
PRINCIPAL FUNDS, INC.0.00%3,912-771-16.46%Jan 31, 2024
John Hancock Funds II0.00%3,468--Feb 29, 2024

Kiniksa Pharmaceuticals's largest mutual fund holder by % of total assets is "WANGER ADVISORS TRUST", owning 272.45K shares, compromising 0.50% of its total assets.

Kiniksa Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 242-98.75%
31 Mar, 241606.67%
31 Dec, 231503.45%
30 Sep, 231456.62%
30 Jun, 23136-2.16%
31 Mar, 231392.96%
31 Dec, 2213517.39%
30 Sep, 2211518.56%
30 Jun, 2297-5.83%
31 Mar, 22103-6.36%
31 Dec, 211100.92%
30 Sep, 21109-6.03%
30 Jun, 21116-1.69%
31 Mar, 211181.72%
31 Dec, 201164.50%
30 Sep, 2011114.43%
30 Jun, 209727.63%
31 Mar, 207624.59%
31 Dec, 196115.09%
30 Sep, 1953-14.52%
30 Jun, 196210.71%
31 Mar, 19567.69%
31 Dec, 1852-3.70%
30 Sep, 185431.71%
30 Jun, 1841-

As of 30 Jun 24, 2 institutions are holding Kiniksa Pharmaceuticals's shares, representing a decrease of -98.75% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 241,326-100.00%
31 Mar, 2438,944,11213.77%
31 Dec, 2334,231,785-1.90%
30 Sep, 2334,893,8369.74%
30 Jun, 2331,796,147-0.05%
31 Mar, 2331,813,0055.03%
31 Dec, 2230,289,2361.23%
30 Sep, 2229,920,261-0.02%
30 Jun, 2229,927,684-2.77%
31 Mar, 2230,780,5854.58%
31 Dec, 2129,433,9581.00%
30 Sep, 2129,141,3260.94%
30 Jun, 2128,869,066-0.62%
31 Mar, 2129,048,421-2.43%
31 Dec, 2029,771,5363.76%
30 Sep, 2028,693,14835.75%
30 Jun, 2021,136,79419.49%
31 Mar, 2017,688,96617.04%
31 Dec, 1915,113,844-2.72%
30 Sep, 1915,536,525-6.28%
30 Jun, 1916,577,5201.57%
31 Mar, 1916,320,89318.97%
31 Dec, 1813,718,366-4.87%
30 Sep, 1814,420,957-16.46%
30 Jun, 1817,262,299-

Kiniksa Pharmaceuticals (KNSA) has 1.33K shares outstanding as of 30 Jun 24, down -100.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 240.00%-
31 Mar, 2455.34%2.33%
31 Dec, 2348.77%1.96%
30 Sep, 2349.91%2.40%
30 Jun, 2345.58%2.19%
31 Mar, 2345.61%2.41%
31 Dec, 2243.51%2.34%
30 Sep, 2243.08%2.31%
30 Jun, 2243.19%2.18%
31 Mar, 2244.52%2.42%
31 Dec, 2142.92%2.38%
30 Sep, 2142.44%2.38%
30 Jun, 2142.21%2.33%
31 Mar, 2142.55%2.22%
31 Dec, 2043.74%2.31%
30 Sep, 2043.50%3.27%
30 Jun, 2036.50%3.57%
31 Mar, 2031.97%4.09%
31 Dec, 1927.96%3.48%
30 Sep, 1928.34%3.06%
30 Jun, 1930.43%3.06%
31 Mar, 1931.53%3.93%
31 Dec, 1828.31%3.20%
30 Sep, 1829.76%0.43%
30 Jun, 1883.04%-

As of 30 Jun 24, Kiniksa Pharmaceuticals is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 241-98.82%
31 Mar, 248523.19%
31 Dec, 2369-
30 Sep, 23691.47%
30 Jun, 2368-13.92%
31 Mar, 23799.72%
31 Dec, 227218.03%
30 Sep, 226138.64%
30 Jun, 2244-8.33%
31 Mar, 2248-22.58%
31 Dec, 216210.71%
30 Sep, 21565.66%
30 Jun, 21536.00%
31 Mar, 2150-20.63%
31 Dec, 2063-16.00%
30 Sep, 20752.74%
30 Jun, 207365.91%
31 Mar, 20447.32%
31 Dec, 194151.85%
30 Sep, 1927-30.77%
30 Jun, 1939-2.50%
31 Mar, 194060.00%
31 Dec, 1825-32.43%
30 Sep, 1837-9.76%
30 Jun, 1841-

1 institutional shareholders have increased their position in KNSA stock as of 30 Jun 24 compared to 85 in the previous quarter (a -98.82% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 24--100.00%
31 Mar, 2448-14.29%
31 Dec, 235624.44%
30 Sep, 23454.65%
30 Jun, 234326.47%
31 Mar, 2334-5.56%
31 Dec, 223624.14%
30 Sep, 222911.54%
30 Jun, 2226-13.33%
31 Mar, 223011.11%
31 Dec, 2127-
30 Sep, 2127-12.90%
30 Jun, 2131-22.50%
31 Mar, 214048.15%
31 Dec, 202758.82%
30 Sep, 201721.43%
30 Jun, 2014-41.67%
31 Mar, 2024100.00%
31 Dec, 1912-20.00%
30 Sep, 19157.14%
30 Jun, 1914180.00%
31 Mar, 195-66.67%
31 Dec, 181550.00%
30 Sep, 1810-
30 Jun, 18--

- institutional shareholders have reduced their position in KNSA stock as of 30 Jun 24 compared to 48 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 242-98.75%1,326-100.00%0.00%-1-98.82%--100.00%
31 Mar, 241606.67%38,944,11213.77%55.34%2.33%8523.19%48-14.29%
31 Dec, 231503.45%34,231,785-1.90%48.77%1.96%69-5624.44%
30 Sep, 231456.62%34,893,8369.74%49.91%2.40%691.47%454.65%
30 Jun, 23136-2.16%31,796,147-0.05%45.58%2.19%68-13.92%4326.47%
31 Mar, 231392.96%31,813,0055.03%45.61%2.41%799.72%34-5.56%
31 Dec, 2213517.39%30,289,2361.23%43.51%2.34%7218.03%3624.14%
30 Sep, 2211518.56%29,920,261-0.02%43.08%2.31%6138.64%2911.54%
30 Jun, 2297-5.83%29,927,684-2.77%43.19%2.18%44-8.33%26-13.33%
31 Mar, 22103-6.36%30,780,5854.58%44.52%2.42%48-22.58%3011.11%
31 Dec, 211100.92%29,433,9581.00%42.92%2.38%6210.71%27-
30 Sep, 21109-6.03%29,141,3260.94%42.44%2.38%565.66%27-12.90%
30 Jun, 21116-1.69%28,869,066-0.62%42.21%2.33%536.00%31-22.50%
31 Mar, 211181.72%29,048,421-2.43%42.55%2.22%50-20.63%4048.15%
31 Dec, 201164.50%29,771,5363.76%43.74%2.31%63-16.00%2758.82%
30 Sep, 2011114.43%28,693,14835.75%43.50%3.27%752.74%1721.43%
30 Jun, 209727.63%21,136,79419.49%36.50%3.57%7365.91%14-41.67%
31 Mar, 207624.59%17,688,96617.04%31.97%4.09%447.32%24100.00%
31 Dec, 196115.09%15,113,844-2.72%27.96%3.48%4151.85%12-20.00%
30 Sep, 1953-14.52%15,536,525-6.28%28.34%3.06%27-30.77%157.14%
30 Jun, 196210.71%16,577,5201.57%30.43%3.06%39-2.50%14180.00%
31 Mar, 19567.69%16,320,89318.97%31.53%3.93%4060.00%5-66.67%
31 Dec, 1852-3.70%13,718,366-4.87%28.31%3.20%25-32.43%1550.00%
30 Sep, 185431.71%14,420,957-16.46%29.76%0.43%37-9.76%10-
30 Jun, 1841-17,262,299-83.04%-41---

Kiniksa Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 25, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOS-SaleSell23,075$23.25$536.49K176,061
Jul 25, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOS-SaleSell50,000$25.05$1.25M126,061
Jul 25, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOS-SaleSell63,049$27.01$1.70M63,012
Jul 25, 2024Ragosa Markofficer CHIEF FINANCIAL OFFICERS-SaleSell24,248$24.79$601.11K19,253
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERS-SaleSell5,530$25.03$138.42K64,273
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERS-SaleSell7,924$26.36$208.88K56,349
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERS-SaleSell8,446$27.10$228.89K47,903
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERS-SaleSell100$27.87$2.79K47,803

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 25, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOM-ExemptSell136,124$1.59$216.44K189,147
Jul 25, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOS-SaleSell23,075$23.25$536.49K176,061
Jul 25, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOS-SaleSell50,000$25.05$1.25M126,061
Jul 25, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOS-SaleSell63,049$27.01$1.70M63,012
Jul 25, 2024Ragosa Markofficer CHIEF FINANCIAL OFFICERM-ExemptSell24,248$11.10$269.15K40,412
Jul 25, 2024Ragosa Markofficer CHIEF FINANCIAL OFFICERS-SaleSell24,248$24.79$601.11K19,253
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERS-SaleSell5,530$25.03$138.42K64,273
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERM-ExemptSell22,000$1.86$40.92K60,217
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERS-SaleSell7,924$26.36$208.88K56,349
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERS-SaleSell8,446$27.10$228.89K47,903
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERS-SaleSell100$27.87$2.79K47,803
Jun 07, 2024Cole G Bradleydirector-M-ExemptSell4,373---

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 25, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOM-ExemptBuy136,124$1.59$216.44K199,136
Jul 25, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOM-ExemptSell136,124$1.59$216.44K189,147
Jul 25, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOS-SaleSell23,075$23.25$536.49K176,061
Jul 25, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOS-SaleSell50,000$25.05$1.25M126,061
Jul 25, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOS-SaleSell63,049$27.01$1.70M63,012
Jul 25, 2024Ragosa Markofficer CHIEF FINANCIAL OFFICERM-ExemptBuy24,248$11.10$269.15K43,501
Jul 25, 2024Ragosa Markofficer CHIEF FINANCIAL OFFICERM-ExemptSell24,248$11.10$269.15K40,412
Jul 25, 2024Ragosa Markofficer CHIEF FINANCIAL OFFICERS-SaleSell24,248$24.79$601.11K19,253
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERM-ExemptBuy22,000$1.86$40.92K69,803
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERS-SaleSell5,530$25.03$138.42K64,273
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERM-ExemptSell22,000$1.86$40.92K60,217
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERS-SaleSell7,924$26.36$208.88K56,349
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERS-SaleSell8,446$27.10$228.89K47,903
Jul 25, 2024Paolini John F.officer CHIEF MEDICAL OFFICERS-SaleSell100$27.87$2.79K47,803
Jun 07, 2024Cole G Bradleydirector-A-AwardBuy19,040$19.71$375.28K19,040
Jun 07, 2024Cole G Bradleydirector-M-ExemptBuy4,373--9,373
Jun 07, 2024Cole G Bradleydirector-A-AwardBuy3,173--3,173
Jun 07, 2024Cole G Bradleydirector-M-ExemptSell4,373---
Jun 07, 2024Levy Richard Sdirector-A-AwardBuy19,040$19.71$375.28K19,040
Jun 07, 2024Levy Richard Sdirector-M-ExemptBuy4,373--12,897

The last insider sell of Kiniksa Pharmaceuticals's stock was made by Patel Sanj K on Jul 25 2024, selling 136,124 shares at $1.59 per share (valued at $216.44K).

Kiniksa Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 202431127.27%
Q2 20245432168.75%
Q1 202491947.37%
Q4 202351050.00%
Q3 2023283093.33%
Q2 20234713361.54%
Q1 2023142458.33%
Q4 20223650.00%
Q3 20221412116.67%
Q2 20222521250.00%
Q1 2022122352.17%
Q4 20211--
Q3 202117--
Q2 202192437.50%
Q1 20212411218.18%
Q4 202051729.41%
Q3 202092450.00%
Q2 2020117157.14%
Q1 2020101662.50%
Q4 201942200.00%

3 total buy trades, and 11 total sell trades (buy/sell ratio of 0.27%) were made by Kiniksa Pharmaceuticals's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-8-
Q2 2024---
Q1 2024-11-
Q4 2023-5-
Q3 2023-4-
Q2 2023---
Q1 2023---
Q4 2022-2-
Q3 2022---
Q2 2022---
Q1 2022---
Q4 2021---
Q3 2021---
Q2 2021---
Q1 2021-7-
Q4 2020-4-
Q3 2020-2-
Q2 2020-5-
Q1 2020-7-
Q4 2019---

As of Q3 2024, Insider owners conducted 0 open market buy trades and 8 open market sell trades of Kiniksa Pharmaceuticals's stocks.

Kiniksa Pharmaceuticals Peer Ownership


TickerCompany
GRCLGracell Biotechnologies Inc.
NUVLNuvalent, Inc.
GOSSGossamer Bio, Inc.
CGEMCullinan Oncology, Inc.
LRMRLarimar Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
PHATPhathom Pharmaceuticals, Inc.
VTYXVentyx Biosciences, Inc.
CERECerevel Therapeutics Holdings, Inc.
COGTCogent Biosciences, Inc.
SPROSpero Therapeutics, Inc.
REPLReplimune Group, Inc.
KRONKronos Bio, Inc.
BOLTBolt Biotherapeutics, Inc.
ACLXArcellx, Inc.
GPCRStructure Therapeutics Inc.
NLTXNeurogene Inc.
KURAKura Oncology, Inc.
CHRSCoherus BioSciences, Inc.
KRTXKaruna Therapeutics, Inc.
LYRALyra Therapeutics, Inc.
NVCTNuvectis Pharma, Inc.

KNSA Ownership FAQ


Kiniksa Pharmaceuticals is owned by institutional shareholders (0.00%), insiders (4.15%), and public (95.85%). The largest institutional shareholder of Kiniksa Pharmaceuticals is BARCLAYS PLC (0.05% of total shares) and the top mutual fund owner is WANGER ADVISORS TRUST (0.50% of total shares).

Kiniksa Pharmaceuticals's major institutional shareholders are BARCLAYS PLC, BIRCHVIEW CAPITAL, LP, ADIRONDACK TRUST CO, ADVISOR GROUP HOLDINGS, INC., and CWM, LLC. The top five shareholders own together 0.09% of the company's share outstanding.

As of Jun 2024, there are 2 institutional shareholders of Kiniksa Pharmaceuticals.

BARCLAYS PLC owns 34.84K shares of Kiniksa Pharmaceuticals, representing 0.05% of the company's total shares outstanding, valued at $650K (as of Jun 2024).

As of Jun 2024, BIRCHVIEW CAPITAL, LP holds 30K shares of Kiniksa Pharmaceuticals (KNSA), compromising 0.04% of the company, valued at $560.1K.

ADIRONDACK TRUST CO is the third largest holder of Kiniksa Pharmaceuticals. The company owns 875 of the company's shares outstanding (worth $16.27K).